Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-11

FDA Approved: BENZTROPINE MESYLATE — Original Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

The FDA approved the original application for benztropine mesylate (generic) from Quagen Pharmaceuticals LLC. It is indicated for Parkinson's disease and drug-i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benztropine Mesylate (benztropine mesylate)

Snippet

ORIG AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)